In multivariate analysis, shorter RFS was found in positive FLT3-ITD AML patients (p = 0.025) and shorter OS were observed in group of WBC ≥ 100,000/μL (p = 0.026) and non-CR patients (p = 0.027) (Table 2). Here, FLT3 is linked to acute myeloid leukemia.